BioNote, Inc. (KRX:377740)

BioNote Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	107,341	147,395	681,067	418,612	123,080
Short-Term Investments	298,076	252,773	672.44	70,000	40,000
Trading Asset Securities	-	-	39,722	-	40,531
Cash & Short-Term Investments	405,416	400,168	721,461	488,612	203,610
Cash Growth	1.31%	-44.53%	47.65%	139.97%	2536.24%
Accounts Receivable	22,006	18,174	16,374	83,961	310,577
Other Receivables	3,079	6,690	1,930	117.81	86.83
Receivables	25,085	24,864	18,304	84,079	310,664
Inventory	25,029	30,683	79,038	64,859	53,053
Prepaid Expenses	366.89	500.1	1,763	51.86	20.11
Other Current Assets	9,804	261.77	4,269	3,107	6,080
Total Current Assets	465,700	456,478	824,836	640,709	573,428
Property, Plant & Equipment	92,635	89,594	97,159	98,007	49,659
Long-Term Investments	1,132,268	1,035,075	827,748	743,863	229,701
Goodwill	677.68	5,512	5,512	5,512	-
Other Intangible Assets	3,638	4,750	1,589	354.16	250.09
Other Long-Term Assets	854.79	491.43	157.1	422.15	401.49
Total Assets	1,697,157	1,592,842	1,757,002	1,488,867	853,440
Accounts Payable	2,541	3,520	3,302	5,412	29,670
Accrued Expenses	1,979	1,591	4,689	9,547	2,841
Current Portion of Leases	1,393	1,334	468.57	295.95	137.82
Current Income Taxes Payable	14,207	467.56	35,157	95,913	139,103
Other Current Liabilities	3,536	3,888	5,889	7,105	12,160
Total Current Liabilities	23,656	10,801	49,505	118,273	183,912
Long-Term Leases	2,538	3,594	893.3	473.7	206.61
Long-Term Deferred Tax Liabilities	34,817	21,652	106,300	97,517	30,593
Other Long-Term Liabilities	374.06	219.19	151.11	99.29	31.75
Total Liabilities	61,384	36,266	156,850	216,363	214,744
Common Stock	51,028	51,028	50,938	46,778	2,924
Additional Paid-In Capital	82,744	82,744	80,997	11,877	55,732
Retained Earnings	1,427,616	1,392,828	1,466,034	1,207,900	580,217
Treasury Stock	-3,108	-	-	-	-
Comprehensive Income & Other	77,493	29,976	2,183	5,948	-176.05
Shareholders' Equity	1,635,773	1,556,576	1,600,152	1,272,504	638,696
Total Liabilities & Equity	1,697,157	1,592,842	1,757,002	1,488,867	853,440
Total Debt	3,931	4,928	1,362	769.65	344.44
Net Cash (Debt)	401,485	395,240	720,100	487,842	203,266
Net Cash Growth	1.58%	-45.11%	47.61%	140.00%	-
Net Cash Per Share	3937.74	3875.94	7637.27	5206.96	2172.67
Filing Date Shares Outstanding	101.36	102.06	101.88	93.56	93.56
Total Common Shares Outstanding	101.36	102.06	101.88	93.56	93.56
Working Capital	442,045	445,677	775,331	522,435	389,516
Book Value Per Share	16137.75	15252.17	15706.85	13601.52	6826.88
Tangible Book Value	1,631,457	1,546,313	1,593,051	1,266,638	638,446
Tangible Book Value Per Share	16095.17	15151.61	15637.15	13538.81	6824.21
Land	38,359	38,359	14,541	14,541	14,541
Buildings	28,412	28,002	25,233	25,905	19,475
Machinery	32,481	31,122	38,873	30,865	17,441
Construction In Progress	8,980	2,002	27,821	35,303	4,219

Source: S&P Global Market Intelligence. Standard template. Financial Sources.